Companion animals bring immense social and emotional benefits to human households. However, they can also serve as substantial reservoirs of resistant pathogens and genetic elements. Emerging data highlight that zoonotic antimicrobial resistance represents an escalating challenge at the human-animal interface. While owned pets receive frequent attention, shelter animals have remained largely unmonitored. A pivotal investigation now characterizes the oral microbiome and resistance profiles in shelter canines, presenting crucial insights for human medicine.

Mapping the Oral Microbiome of Canine Shelter Populations

Researchers evaluated oral swabs collected from 81 shelter dogs across Japan using 16S rRNA gene amplicon sequencing. Consequently, the team established a comprehensive taxonomic breakdown of the canine oral cavity. At the phylum level, Pseudomonadota and Bacteroidota dominated the samples, mirroring trends observed in domestic household pets. In addition, the analysis revealed that Porphyromonas, Frederiksenia, and Moraxella represented the most prevalent genera across the cohort.

These microbial findings demonstrate that shelter dogs maintain an oral ecosystem remarkably similar to that of family pets. Therefore, shelter environments do not foster a completely isolated or novel microflora. Instead, shelter dogs acquire and retain standard canine commensals alongside opportunistic bacteria. Furthermore, environmental crowding, shared enclosures, and previous unknown antibiotic exposures may intensify bacterial exchange within shelters. Clinicians frequently encounter these same organisms during wound evaluations following animal bites. Because oral commensals easily seed traumatic puncture wounds, understanding the baseline canine oral flora allows physicians to anticipate potential soft tissue complications. Thus, characterizing this oral biome provides foundational insight into community-acquired zoonoses.

High Burden of Zoonotic Antimicrobial Resistance Genes

The molecular screening uncovered an alarming distribution of antimicrobial resistance determinants within the canine oral cavity. Specifically, investigators screened genomic DNA by PCR for resistance genes targeting major antimicrobial classes. These classes encompassed beta-lactams, tetracyclines, sulfonamides, phenicols, and macrolide-lincosamide-streptogramin B agents.

Most strikingly, researchers detected the cfxA gene, which confers resistance to cephamycins and penicillins, in every single animal tested. In addition, sulfonamide resistance genes showed widespread distribution, with sul1 appearing in 66 of 81 dogs and sul2 in 65 dogs. Tetracycline resistance via tet(M) occurred in 65 animals, while the phenicol exporter floR emerged in 39 subjects. Notably, investigators identified the mecA gene in 17 samples and the macrolide resistance marker erm(B) in 15 samples.

These results indicate that shelter canines serve as extensive, silent pools of clinically relevant resistance factors. Consequently, dogs can harbor mobile genetic elements even without recent documented antibiotic therapy. Moreover, these genes can readily transfer across bacterial species via horizontal gene transfer in polymicrobial oral biofilms. Thus, shelter dogs present an overlooked reservoir capable of disseminating drug-resistant traits into adoptive households.

Opportunistic Pathogens and Clinical Risks for Human Contacts

Beyond resistance determinants, the study identified several bacterial genera with confirmed human pathogenic potential. In particular, the oral swabs contained Capnocytophaga, Pasteurella, Fusobacterium, Campylobacter, and Corynebacterium. Each of these organisms poses defined infectious hazards during bites, scratches, or contact with saliva.

Pasteurella species represent the primary cause of rapidly progressive cellulitis and soft tissue abscesses after animal bites. Furthermore, Capnocytophaga species, notably Capnocytophaga canimorsus, cause fulminant sepsis, purpura fulminans, and peripheral gangrene in susceptible patients. Asplenic patients, elderly individuals, and immunocompromised hosts face devastating outcomes from such exposures. In addition, Fusobacterium species promote synergistic anaerobic necrosis and extensive tissue destruction in puncture wounds.

Meanwhile, Campylobacter carriage introduces serious gastrointestinal threats if basic hygiene fails after pet handling. Because shelter dogs frequently interact closely with caretakers and prospective owners, bacterial transmission can occur without overt bite trauma. Casual encounters, including facial licks on broken skin or mucous membranes, facilitate bacterial transfer. Accordingly, clinicians must recognize that canine saliva harbors complex polymicrobial threats capable of causing severe human infections.

Implications for Empirical Therapy in Bite Wound Management

The high prevalence of resistance determinants directly influences how clinicians manage animal bite wounds in urgent care. Historically, medical guidelines recommend empirical amoxicillin-clavulanate for mammalian bite injuries. However, the universal detection of cfxA alongside mecA carriage raises legitimate therapeutic concerns regarding traditional beta-lactam regimens.

Furthermore, tetracycline resistance via tet(M) and sulfonamide resistance through sul1 and sul2 complicate second-line options for penicillin-allergic patients. For instance, clinicians often choose doxycycline or trimethoprim-sulfamethoxazole when beta-lactam allergy precludes standard therapies. If canine pathogens carry corresponding resistance determinants, empirical second-line therapy may suffer early failure. Therefore, physicians must maintain vigilant surveillance over wound healing after initiating treatment.

In response, clinicians should routinely obtain microbiological cultures before starting antibiotics on infected, purulent wounds. In addition, early surgical irrigation, careful debridement, and thorough cleansing remain vital steps in preventing systemic dissemination. Clinicians must not rely solely on antimicrobial pharmacotherapy. Instead, combining prompt wound debridement with targeted susceptibility testing ensures optimal recovery while curbing the selection of resistant strains.

One Health Interventions and Pet Adoption Protocols

Preventing the dissemination of multidrug-resistant bacteria requires collaborative One Health frameworks linking veterinary medicine and human healthcare. Historically, antimicrobial surveillance initiatives focused almost entirely on agricultural livestock and food production systems. However, companion animals live in intimate proximity to human families, sharing physical environments and daily contacts.

Shelter dogs frequently originate from stray backgrounds or abandoned households, carrying unrecorded medical histories. Consequently, shelter intake protocols should incorporate routine veterinary health examinations and strict antimicrobial stewardship. Veterinary teams must avoid indiscriminate empirical antibiotic use for shelter residents. In addition, shelters should implement robust infection control protocols, proper kennel sanitation, and quarantine periods for diseased animals.

Furthermore, educational campaigns must guide prospective pet owners prior to final adoption. Shelter staff should educate adopters on hand hygiene, safe handling, and avoiding canine saliva contact on non-intact skin. Similarly, family physicians should inquire about new household pets when patients present with unexplained soft tissue infections or persistent colonization. Through proactive cross-disciplinary cooperation, healthcare systems can preserve antibiotic efficacy while safeguarding human and animal welfare.

How do antimicrobial resistance genes in shelter dogs spread to humans?

Antimicrobial resistance genes transfer to humans primarily through direct contact with canine saliva, puncture bites, scratches, or compromised skin barriers. In addition, resistant oral bacteria colonize the human skin and mucous membranes during casual interactions like licking. Within shared environments, horizontal gene transfer occurs readily among bacterial species through mobile genetic elements. Consequently, close physical intimacy between owners and newly adopted pets facilitates the silent transmission of resistant organisms into the community.

Which patients face the highest risk of severe zoonotic canine infections?

Immunocompromised individuals face the greatest danger of developing life-threatening complications following exposure to canine oral pathogens. Specifically, asplenic patients, individuals with advanced hepatic cirrhosis, and oncology patients undergoing active chemotherapy exhibit severe vulnerability to Capnocytophaga canimorsus and Pasteurella multocida. These bacteria can precipitate rapid septic shock, purpura fulminans, and disseminated intravascular coagulation. Therefore, clinicians must educate high-risk patients to avoid canine mouth contact and seek immediate medical evaluation after any bite or scratch.

How should clinicians adjust empirical antibiotic treatment for canine bite wounds?

Clinicians should initiate empirical amoxicillin-clavulanate while recognizing that resistance genes like cfxA and mecA may cause unexpected treatment failure. Furthermore, physicians must collect wound swabs for aerobic and anaerobic culture before administering antibiotics whenever purulence or severe tissue involvement exists. If a patient cannot take penicillins, alternative regimens require cautious monitoring because resistance to tetracyclines and sulfonamides remains prevalent. Ultimately, aggressive wound cleansing, thorough debridement, and tailored therapy based on susceptibility testing prevent clinical deterioration.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

Makau RM et al. Characterization of the oral microbiota and antimicrobial resistance genes in shelter dogs in Japan. J Vet Med Sci. 2026 Sep 17. doi: 10.1292/jvms.26-0387. PMID: 42749632.

Damborg P et al. Bacterial zoonoses transmitted by household pets: state-of-the-art and future perspectives for Europe. Clin Microbiol Infect. 2016;22(2):118-125.

World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015.